We have previously demonstrated that the importance of endothelium-derived hyperpolarizing factor (EDHF) increases as the vessel size decreases and that endothelium-derived hydrogen peroxide (H 2 O 2 ) is an EDHF in animals and humans, for which endothelial nitric oxide synthase (eNOS) is the major source. Recent studies have suggested the important role of the bone marrow (BM) in modulating cardiovascular and metabolic functions.
T he endothelium plays an important role in maintaining vascular homeostasis by synthesizing and releasing several vasodilators, including prostacyclin, nitric oxide (NO), and endothelium-derived hyperpolarizing factor (EDHF). [1] [2] [3] It is widely accepted that EDHF plays an important role in modulating vascular tone, especially in microvessels. 4, 5 In addition, endothelial function is impaired by hypertension, glucose intolerance, insulin resistance, dyslipidemia, obesity, and metabolic syndrome. 6 -9 
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We have previously demonstrated that endotheliumderived hydrogen peroxide (H 2 O 2 ) is an EDHF in mouse 10 and human 11 mesenteric arteries and porcine coronary microvessels. 12 Other investigators confirmed the importance of H 2 O 2 as an EDHF 13 in human 14 and canine 15, 16 coronary microvessels and porcine pial arteries. 17 We also have demonstrated that endothelial nitric oxide synthase (eNOS) is a major source of EDHF/H 2 O 2 , 10 where copper, zincsuperoxide dismutase plays an important role to dismutate eNOS-derived superoxide anions to EDHF/H 2 O 2 18, 19 and that endothelial NOSs system plays different roles depending on the vessel size, serving as the NO-generating system in large arteries and as the EDHF/H 2 O 2 -generating system in microvessels in mice. 20 Furthermore, we have recently demonstrated that when the all 3 NOSs [eNOS, neuronal NOS (nNOS), and inducible NOS (iNOS)] are genetically deleted in mice, acute myocardial infarction develops spontaneously associated with unique phenotypes that resemble metabolic syndrome in humans, including glucose intolerance, hypertension, dyslipidemia, and visceral obesity. 21 These results indicate the close coupling between microvascular endothelial functions and metabolic disorders, although the detailed mechanisms remain to be elucidated.
It has been recently demonstrated that some blood cells [eg, neutrophils, macrophages, and endothelial progenitor cells (EPCs) 22 ] are involved in the development of cardiovascular diseases, including atherosclerosis, 23 cardiovascular events, 24 vasospastic angina, 25 and angiogenesis. 26 However, it also has been demonstrated that bone marrow (BM)-derived cells do not directly differentiate into vascular endothelial or smooth muscle cells in mouse models of atherosclerosis [27] [28] [29] and of chronic endothelial dysfunction. 30 We hypothesized that the BM plays an important role in maintaining microvascular endothelial and metabolic functions. To test this hypothesis, we examined whether BM transplantation improves microvascular endothelial and metabolic functions in eNOS Ϫ/Ϫ mice, an established animal model of atherosclerosis and metabolic disorders, and if so, what mechanisms are involved.
Methods

Animals
An expanded Methods section is available in the online Data Supplement.
The present study was reviewed and approved by the Committee on Ethics of Animal Experiments of Tohoku University. Male mice aged 8 weeks were used. The eNOS Ϫ/Ϫ mice were originally provided by P. Huang (Harvard Medical School, Boston, MA). The eNOS Ϫ/Ϫ mice were backcrossed to C57BL/6 mice over 10 generations. Thus, C57BL/6 mice were used as a wild-type (WT) control. We generated n/eNOS Ϫ/Ϫ mice by crossing nNOS Ϫ/Ϫ and eNOS Ϫ/Ϫ mice, as previously reported. 31 eNOS Ϫ/Ϫ /adiponectin (APN)
Ϫ/Ϫ mice were generated by crossing eNOS Ϫ/Ϫ and APN Ϫ/Ϫ mice (Jackson Laboratory, Bar Harbor, ME). Systolic blood pressure was measured by tail-cuff method.
BM Transplantation
BM transplantation was performed as described previously. 32 After transplantation, the mice were placed on a regular chow diet for 6 weeks. We generated green fluorescent protein (GFP)-positive WT and GFP-positive eNOS Ϫ/Ϫ mice by crossing with transgenic mice ubiquitously expressing GFP. 33 
Organ Chamber Experiments
Isometric tension was recorded using isolated small mesenteric arteries (Ϸ200 m) and the aorta, as previously described. 9, 10, 18, 20 Rings were precontracted with prostaglandin F 2␣ . The contributions of vasodilator prostaglandins (PGs), NO and EDHF to acetylcholine (ACh)-induced endothelium-dependent relaxation were determined by the inhibitory effect of indomethacin, N -nitro-l-arginine (L-NNA) in the presence of indomethacin, and a combination of charybdotoxin and apamin, respectively. 9, 10, 18, 20 To examine the involvement of endothelium-derived H 2 O 2 in the EDHF-mediated responses, the inhibitory effect of catalase, a specific scavenger of H 2 O 2 , was examined. 9, 10, 18, 20 
Electrophysiological Experiments
The rings of small mesenteric arteries were placed in experimental chambers perfused with Krebs solution containing indomethacin and L-NNA. A fine glass capillary microelectrode was impaled into the smooth muscle from the adventitial side of mesenteric arteries, and changes in membrane potentials produced by ACh were continuously recorded. 9, 10, 18, 20 
Histological Analysis
Adipose tissue was fixed in zinc fixative and embedded in paraffin. After blocking of endogenous biotin and avidin binding sites, sections were subjected to immunohistochemical staining overnight at 4°C with an anti-F4/80 monoclonal antibody. Immune complexes were detected with biotinylated secondary antibodies, horseradish peroxidase-conjugated streptavidin and the peroxidase substrate diaminobenzidine.
Glucose Tolerance Tests
For the glucose tolerance test, mice were fasted overnight. Glucose (1 g/kg body weight) was injected intraperitoneally and blood was collected from the tail vein at different time points. 34 
Statistical Analysis
Statistical analysis was performed with JMP 9.0 (SAS Institute Inc, Cary, NC). Results are shown as meanϮSEM. Dose-response curves were analyzed by 2-way ANOVA followed by Tukey HSD test for multiple comparisons. Other variables were analyzed by Student t test or 1-way ANOVA followed by Tukey HSD test for multiple comparisons. PϽ0.05 was considered to be statistically significant.
Results
Chimerism in Transplanted Mice
Chimerism in transplanted eNOS Ϫ/Ϫ mice was analyzed by the percentage of EGFP ϩ nucleated blood cells found in peripheral blood at 5 weeks after BM transplantation. All animals showed Ͼ85% chimerism (WT-BM, 90.2Ϯ0.6%; eNOS Ϫ/Ϫ -BM, 87.3Ϯ0.3%, nϭ5-7).
Body Weight, Systolic Blood Pressure, and Blood Cell Counts
In the present study, we examined 4 groups of mice, including sham-transplanted (control) WT and eNOS Ϫ/Ϫ mice and eNOS Ϫ/Ϫ mice transplanted with WT-BM or eNOS Ϫ/Ϫ -BM (Online Table I ). At baseline, body weight was greater in the 3 eNOS Ϫ/Ϫ groups than in WT. At 6 weeks after BM or vehicle injection, there was no significant difference in body weight among the 4 groups. Systolic blood pressure was significantly higher in the 3 eNOS Ϫ/Ϫ groups compared with WT throughout the experimental period (Online Table I ). At 5 weeks after BM or vehicle injection, control eNOS Ϫ/Ϫ mice had higher white and red blood cell counts, increased hemoglobin levels, and decreased platelet count compared with control WT. The increased white and red cell counts and hemoglobin levels were normalized by transplantation with WT-BM or eNOS Ϫ/Ϫ -BM, whereas platelet count was unchanged (Online Table I ).
Endothelium-Dependent Relaxations and Hyperpolarizations
In isolated mesenteric arteries of control WT mice, ACh elicited concentration-dependent relaxations, which were resistant to indomethacin (vasodilator PGs component) or indomethacin plus L-NNA (NO component), but was highly sensitive to the combination of apamin and charybdotoxin in the presence of indomethacin and L-NNA (EDHF component) ( Figure 1A ). In mesenteric arteries of control eNOS Ϫ/Ϫ mice, endothelium-dependent, EDHF-mediated relaxations to ACh were markedly attenuated compared with those of WT mice ( Figure 1B ), a consistent finding with our previous studies. 10, 20 Transplantation with WT-BM but not that with eNOS Ϫ/Ϫ -BM markedly improved the EDHF-mediated relaxations ( Figure 1C and 1D). The enhanced component of EDHF-mediated relaxations was abolished in endotheliumdenuded mesenteric artery (Online Figure I , A). In addition, this enhanced component was markedly inhibited by catalase, indicating that the improved responses were mediated by endothelium-derived H 2 O 2 ( Figure 1E ). Similarly, EDHFmediated relaxations in WT mice mesenteric arteries were markedly inhibited by catalase, whereas NO-mediated relaxations in WT mice aorta were not affected by catalase (Online Figure II , A and B). Absolute values of contractions of mesenteric artery to prostaglandin F 2␣ were comparable among all the groups (Online Table II 
Endothelium-Independent Relaxations
There was no significant difference in endotheliumindependent relaxations to NS1619 [an opener of calcium-activated potassium (K Ca ) channels] or sodium nitroprusside (SNP) in mesenteric arteries and the aorta between WT-BM and eNOS Ϫ/Ϫ -BM mice (Online Figure III , A through D). In addition, there was no significant difference in endotheliumindependent relaxations of mesenteric artery to SNP regardless of the presence or absence of the endothelium in WT-BM eNOS Ϫ/Ϫ mice (Online Figure I, B) . Furthermore, the relaxations to NS1619 were unaltered by catalase in mesenteric arteries when transplanted with WT-BM (Online Figure 
Immunostaining of Mesenteric Artery and Aorta in eNOS
؊/؊ Mice
Immunofluorescence staining was performed in mesenteric arteries and the aorta of GFP ϩ WT-BM eNOS Ϫ/Ϫ mice and GFP ϩ eNOS Ϫ/Ϫ -BM eNOS Ϫ/Ϫ . We observed a small number of GFP-positive BM-derived cells in the adventitia of mesenteric artery (WT-BM, 0.6Ϯ0.6; eNOS Ϫ/Ϫ -BM, 0.8Ϯ0.2, nϭ5 each, not statistically significant) but not in the intima or media of mesenteric artery or in the aorta (Online Figure IV,  A) . Immunohistochemical staining was performed in mesen- 
Flow Cytometry Analysis to Assess EPC
Glucose Tolerance Tests and Plasma Levels of Lipids
Glucose tolerance test was performed in all 4 groups at 5 weeks after BM or vehicle injection. Although plasma glucose levels were comparable at baseline, the levels were significantly higher in control eNOS Ϫ/Ϫ mice at 30 and 60 minutes compared with WT mice (Figure 3 ). WT-BM transplantation normalized glucose tolerance in eNOS Ϫ/Ϫ mice to the level in WT mice, whereas eNOS Ϫ/Ϫ -BM transplantation was without the effects ( Figure 3) . The plasma levels of total cholesterol, LDL cholesterol and triglycerides were also significantly higher in control eNOS Ϫ/Ϫ mice compared with WT mice, and the levels of total cholesterol and LDL cholesterol were significantly reduced with WT-BM transplantation but not with eNOS
-BM transplantation (Online Table I ). In contrast, the plasma levels of HDL cholesterol were significantly higher in control eNOS Ϫ/Ϫ mice than in control WT mice and were unchanged with the BM transplantation (Online Table I ).
Visceral Fat and Plasma Levels of Adiponectin
The size of epididymal white adipose cells, one of the representative visceral fats, was significantly larger in control eNOS Ϫ/Ϫ mice than in control WT mice and was diminished when transplanted with WT-BM but not with eNOS Ϫ/Ϫ -BM ( Figure 4A and 4B) . We also performed immunostaining for the F4/80 antigen, a specific marker for mature macrophages, and calculated the percentage of F4/80-expressing cells in the epididymal white adipose tissue. The percentage was significantly higher in eNOS Ϫ/Ϫ mice than in WT mice, and aggregates of F4/80-expressing cells were noted in control eNOS Ϫ/Ϫ but not in control WT mice ( Figure 4A through 4C). The percentage was significantly reduced with WT-BM transplantation but not with eNOS Ϫ/Ϫ -BM transplantation ( Figure 4A and 4C) . Plasma adiponectin level was significantly reduced in eNOS Ϫ/Ϫ mice compared with WT mice and was significantly improved with WT-BM transplantation but not with eNOS Ϫ/Ϫ -BM transplantation ( Figure 4D ). 
Experiments With eNOS
Protein Expression of eNOS and nNOS
As expected, eNOS protein expression of mesenteric arteries was absent in eNOS Ϫ/Ϫ mice transplanted with WT-BM or eNOS Ϫ/Ϫ -BM ( Figure 6A ). In contrast, nNOS protein expression of mesenteric arteries was significantly greater in eNOS Ϫ/Ϫ mice transplanted with WT-BM compared with those with eNOS Ϫ/Ϫ -BM, whereas it was comparable in the aorta ( Figure 6B ). In eNOS Ϫ/Ϫ /APN Ϫ/Ϫ mice, WT-BM transplantation did not alter nNOS protein expression of mesenteric arteries ( Figure 6C ).
Experiments With n/eNOS ؊/؊ Mice
We also performed the experiments with n/eNOS Ϫ/Ϫ mice with or without WT-BM transplantation. Unlike eNOS Ϫ/Ϫ mice, WT-BM transplantations caused no beneficial effects on endothelium-dependent relaxations of mesenteric arteries ( Figure 7A and 7B) . In contrast, WT-BM transplantation to n/eNOS Ϫ/Ϫ mice tended to enhance indomethacin-sensitive endothelium-dependent relaxations, suggesting an upregulation of vasodilator prostaglandins ( Figure 7A and 7B) . Endothelium-independent relaxations of mesenteric arteries to NS1619 or SNP were unaltered with WT-BM transplantation in n/eNOS Ϫ/Ϫ mice (Online Figure VIII, A and B) .
Effect of Adiponectin Treatment to eNOS ؊/؊ Mice
We intraperitoneally injected recombinant mouse adiponectin (500 g/kg BW) or PBS into male eNOS Ϫ/Ϫ mice at the age of 13 weeks once daily for 7 days. Treatment with adiponectin significantly improved EDHF-mediated relaxations in mesenteric arteries compared with PBS-treated mice ( Figure  8A and 8B). In contrast, the adiponectin treatment had no significant effects in the aorta ( Figure 8C and 8D) . Endothelium-independent relaxations of mesenteric arteries to NS1619 or SNP were comparable between adiponectintreated and PBS-treated groups (Online Figure IX) .
Discussion
The major findings of the present study were as follows: (1) eNOS Ϫ/Ϫ mice were characterized by absence of NOmediated relaxations and reduced EDHF-mediated relaxations associated with impaired glucose tolerance and dyslipidemia, (2) WT-BM transplantation to eNOS Ϫ/Ϫ mice almost normalized EDHF-mediated endothelium-dependent relaxations of mesenteric arteries and glucose tolerance, (3) the enhancing effects of WT-BM transplantation on the EDHFmediated responses were mediated primarily by endotheliumderived H 2 O 2 , and (4) the beneficial effects of WT-BM transplantation on EDHF-mediated responses in eNOS Ϫ/Ϫ mice were mediated by adiponectin and nNOS. To the best of our knowledge, this is the first study that demonstrates that BM plays an essential role for microvascular endothelial and metabolic functions, for which adiponectin and nNOS are substantially involved.
Effects of WT-BM Transplantation
In eNOS Ϫ/Ϫ mice, WT-BM transplantation markedly improved and almost normalized EDHF-mediated and endothelium-dependent relaxations, whereas eNOS Ϫ/Ϫ -BM transplantation was without the effects. We have previously demonstrated that EDHF-mediated relaxations and hyperpolarizations of mesenteric arteries are markedly reduced (but not absent) in eNOS Ϫ/Ϫ mice, where the remaining 2 NOSs (nNOS and iNOS) play a compensatory role. 10, 20 It is known that eNOS generates superoxide anions under normal conditions from reductase domain, and only when pathologically uncoupled (eg, depletion of BH4 and/or L-arginine) it generates superoxide anions from oxidase domain and that L-arginine analogues inhibits the latter process alone. 35 We have previously reported that H 2 O 2 as an EDHF is generated from reductase domain of eNOS, which is not affected by L-arginine analogues. 20 Several studies have previously addressed the effects of BM transplantation; eNOS Ϫ/Ϫ -BM transplantation to WT mice was found to aggravate vascular lesions in a mouse model of carotid artery ligation, 36 BM-derived EPCs from eNOS Ϫ/Ϫ mice showed reduced angiogenic effects compared with EPCs from WT mice, 37 and WT-BM transplantation to eNOS Ϫ/Ϫ mice ameliorated cardiac fibrosis and capillary density in pressure overload. 38 Taken together with the present results, it is highly possible that BM plays an important role in modulating microvascular endothelial functions.
The mechanisms of differentiation of BM-derived EPCs have been extensively investigated 39, 40 ; however, it has been recently demonstrated that BM-derived cells do not differentiate into vascular endothelial or smooth muscle cells in mice. [27] [28] [29] [30] In the present study, we also were unable to observe the presence of BM-derived cells in the vascular wall of eNOS Ϫ/Ϫ mice transplanted with GFP-positive BM or eNOS protein expression in mesenteric arteries of eNOS Ϫ/Ϫ mice transplanted with WT-BM. Furthermore, WT-BM transplantation did not improve endothelial-dependent relaxations of the aorta from eNOS Ϫ/Ϫ mice, although it markedly improved the responses of mesenteric arteries. Thus, we consider that the improvement of endothelium-dependent relaxations of mesenteric artery from eNOS Ϫ/Ϫ mice by WT-BM transplantation was mediated by humoral factor(s) but not by differentiation of EPCs or other BM-derived progenitor cells to endothelial cells.
Roles of Adiponectin
Adiponectin is an abundant plasma protein specifically secreted by adipocytes, 41 playing an important role in the regulation of glucose and lipid metabolism. 42 The serum levels of adiponectin are inversely correlated with the extent of visceral fat. 43 Moreover, hypoadiponectinemia is associated with reduced endothelium-dependent dilatation in both diabetic and nondiabetic human subjects. 44 We and others showed that eNOS Ϫ/Ϫ mice had low serum levels of adiponectin and hypertrophic visceral adipose cells. 21, 45 Interestingly, in the present study, WT-BM transplantation to eNOS Ϫ/Ϫ mice decreased the size of visceral adipose cells and increased plasma levels of adiponectin, whereas WT-BM transplantation had no effect on the adiponectin level in control eNOS
mice. Furthermore, the F4/80 antigen, a marker for mature mouse macrophages, was highly expressed in epididymal white adipose tissue of eNOS Ϫ/Ϫ mice compared with WT mice and WT-BM transplantation to eNOS Ϫ/Ϫ mice decreased these expressions. Obesity and metabolic syndrome are associated with macrophage infiltration in adipose tissue. 46, 47 Macrophage-specific expression of adiponectin suppresses the development of obesity and macrophage infiltration to adipose tissue and improved insulin sensitivity in mice. 48 Transgenic mice expressing monocyte chemoattractant protein-1 (MCP-1) in the adipose tissue exhibit enhanced macrophage infiltration and insulin resistance, whereas in MCP-1-deficient mice, macrophage accumulation in the adipose tissue, insulin resistance, and hepatic steatosis are improved associated with increased serum levels of adiponectin. 34 These results suggest the metabolic syndrome-like phenotypes of eNOS Ϫ/Ϫ mice is caused by reduced adiponectin levels and enhanced macrophage infiltration, both of which are related to reduced eNOS functions.
Roles of nNOS
Adiponectin promotes phosphorylation of AMP-activated protein kinase, protein kinase Akt/protein kinase B, and eNOS in HUVEC in vitro. 49 The eNOS expression in the aorta from adiponectin Ϫ/Ϫ mice is decreased in vivo, whereas (A and B) . On the other hand, it had no effect to aorta (C and D).
adenovirus-mediated delivery of adiponectin increases eNOS expression in the aorta from KK-Ay mice (a mouse model for type 2 diabetes) and adiponectin Ϫ/Ϫ mice. 50 These results indicate that adiponectin enhances eNOS expression and activity. In the present study, nNOS expression in mesenteric arteries was enhanced in eNOS Ϫ/Ϫ mice when transplanted with WT-BM but not with eNOS Ϫ/Ϫ -BM. nNOS is usually expressed in nerve tissues but is also constitutively expressed in endothelial cells as is eNOS. 51 Especially when expression and activity of eNOS are reduced, nNOS (and iNOS) exerts compensatory effects. 52, 53 Indeed, EDHF-mediated and endothelium-dependent relaxations were totally absent only when all 3 NOSs were deleted in mice. 20 To confirm our hypothesis on the roles of adiponectin and nNOS, we also performed experiments with eNOS Ϫ/Ϫ / APN Ϫ/Ϫ mice and eNOS Ϫ/Ϫ /nNOS Ϫ/Ϫ mice. In both mice, endothelium-dependent and EDHF-mediated relaxations of mesenteric arteries were reduced compared with control eNOS Ϫ/Ϫ mice. Importantly, unlike eNOS Ϫ/Ϫ mice, WT-BM transplantation failed to improve EDHF-mediated relaxations in those mice. Furthermore, the treatment with recombinant adiponectin improved EDHF-mediated relaxations in eNOS Ϫ/Ϫ mice as did WT-BM transplantation. In addition, in eNOS Ϫ/Ϫ /APN Ϫ/Ϫ mice, WT-BM transplantation enhanced relaxations mediated by vasodilator PGs. These results suggest that both adiponectin-dependent and adiponectinindependent mechanisms are involved in the effects of WT-BM transplantation in eNOS Ϫ/Ϫ mice. Although it remains to be examined whether adiponectin also enhances the expression and activity of nNOS as in the case of eNOS, it is conceivable that increased adiponectin levels by WT-BM transplantation may upregulate nNOS in the endothelium of mesenteric arteries from eNOS Ϫ/Ϫ mice, enhancing endothelium-dependent and EDHF-mediated relaxations. Although the molecular mechanism of nNOS upregulation by adiponectin remains to be elucidated, it is conceivable that anti-inflammatory effects of adiponectin and those of eNOS-derived H 2 O 2 /EDHF may be involved.
Study Limitations
Several limitations should be mentioned for the present study. First, although we were able to elucidate the important roles of adiponectin and nNOS in the beneficial effects of WT-BM transplantation in eNOS Ϫ/Ϫ mice, the detailed molecular mechanisms remain to be elucidated. Second, it remains to be determined why WT-BM transplantation had no beneficial effects on endothelial function of the aorta. Third, although WT-BM transplantation improved EDHF-mediated relaxations in eNOS Ϫ/Ϫ mice, blood pressure was not improved. Several possibilities should be considered to explain this observation, including the limitation of tail-cuff method to measure blood pressure and the partial improvement of the responses as compared with genetic modulation. 13 Fourth, in the present study, WT-BM transplantation improved (almost normalized) microvascular endothelial functions, glucose tolerance, lipid profiles, adiponectin levels, and macrophage infiltration in the visceral adipose tissue, the cause-result relationships among those changes remain to be established. In addition, the background underlying these changes (eg, renin-angiotensin system and oxidative stress) remains to be examined.
Clinical Implications
The present study has important clinical implications. eNOS Ϫ/Ϫ mice are characterized by the phenotypes resembling metabolic syndrome in humans 21, 54, 55 and thus could be regarded as an animal model of atherosclerosis and metabolic disorders. Since WT-BM transplantation almost normalized microvascular endothelial and metabolic functions, the present results suggest that BM function could be a new therapeutic target of cardiovascular and metabolic disorders. It remains to be examined in future studies what therapeutic options could improve BM functions in atherosclerotic animals models as well as patients with athero-metabolic disorders.
Conclusions
The present study provides the first evidence that BM plays an important role in modulating microvascular endothelial and metabolic functions, for which adiponectin and nNOS may be involved.
